Search hospitals
>
Ohio
>
Columbus
Arthur G. James Cancer Hospital - Ohio State University
Claim this profile
Columbus, Ohio 43202
Global Leader in Lymphoma
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Leukemia
Conducts research for Cancer
491 reported clinical trials
16 medical researchers
Summary
Arthur G. James Cancer Hospital - Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Lymphoma, Lung Cancer, Breast Cancer, Leukemia, Cancer and other specialties. Arthur G. James Cancer Hospital - Ohio State University is involved with conducting 491 clinical trials across 357 conditions. There are 16 research doctors associated with this hospital, such as Uma Borate, MD, Alice Mims, Sagar Sardesai, MD, and David O'Malley, MD.
Area of expertise
Lymphoma
Arthur G. James Cancer Hospital - Ohio State University has run 61 trials for Lymphoma. Some of their research focus areas include:
Lung Cancer
Arthur G. James Cancer Hospital - Ohio State University has run 52 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Uma Borate, MD
Ohio State University Comprehensive Cancer Center
4 years of reported clinical research
Alice Mims
Ohio State University Comprehensive Cancer Center
6 years of reported clinical research
Sagar Sardesai, MD
Ohio State University Comprehensive Cancer Center
1 year of reported clinical research
David O'Malley, MD
Ohio State University Comprehensive Cancer Center
2 years of reported clinical research
Clinical Trials running at Arthur G. James Cancer Hospital - Ohio State University
Acute Myeloid Leukemia
Myelofibrosis
Chronic Lymphocytic Leukemia
Lung Cancer
Multiple Myeloma
Follicular Lymphoma
Mantle Cell Lymphoma
Myelodysplastic Syndrome
Leukemia
Acute Myelogenous Leukemia
SEA-CD70
for Myelodysplastic Syndrome and Acute Myeloid Leukemia
This trial is testing a new drug, SEA-CD70, alone and with azacitidine, to see if it is safe and works for adults with certain blood cancers that haven't responded to other treatments. The study will determine the best dose and check for side effects. Azacitidine is a treatment that improves survival, reduces the need for transfusions, and lowers the risk of progression to acute myeloid leukemia in patients with higher risk myelodysplastic syndromes.
Recruiting
1 award
Phase 1
10 criteria
Emavusertib (+ Venetoclax)
for Acute Myeloid Leukemia
This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with AML or higher- risk Myelodysplastic Syndrome (hrMDS). Patients enrolling in the Phase 1 dose escalation of the study must meet one of the following criteria prior to consenting to the study: * Relapse/refractory (R/R) AML with FMS-like tyrosine kinase-3 (FLT3) mutations who have been previously treated with a FLT3 inhibitor * R/R AML with spliceosome mutations of splicing factor 3B subunit 1 (SF3B1) or U2AF1 * R/R hrMDS with spliceosome mutations of SF3B1 or U2 small nuclear RNA auxiliary factor 1 (U2AF1) * Number of pretreatments: 1 or 2 The Phase 2a Dose Expansion will be in 3 Cohorts of patients: 1. R/R AML with FLT3 mutations who have been previously treated with a FLT3 inhibitor; 2. R/R AML with spliceosome mutations of SF3B1 or U2AF1; and 3. R/R hrMDS (Revised International Prognostic Scoring System \[IPSS-R\] score \> 3.5) with spliceosome mutations of SF3B1 or U2AF1. All patients above have had ≤ 2 lines of prior systemic anticancer treatment. In previous versions of this protocol there was a Phase 1b portion of the study, in which patients with AML or hrMDS received CA-4948 in combination with venetoclax. This part of the study is no longer open for enrollment.
Recruiting
1 award
Phase 1 & 2
9 criteria
Quizartinib + Chemotherapy
for Leukemia
This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute myeloid leukemia (AML).
Recruiting
1 award
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Arthur G. James Cancer Hospital - Ohio State University?
Arthur G. James Cancer Hospital - Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Lymphoma, Lung Cancer, Breast Cancer, Leukemia, Cancer and other specialties. Arthur G. James Cancer Hospital - Ohio State University is involved with conducting 491 clinical trials across 357 conditions. There are 16 research doctors associated with this hospital, such as Uma Borate, MD, Alice Mims, Sagar Sardesai, MD, and David O'Malley, MD.
Where is Arthur G. James Cancer Hospital - Ohio State University located?
**Arthur G. James Cancer Hospital - Ohio State University** - **Location:** 460 W. 10th Ave., Columbus, OH 43210. - **Directions:** Take I-71 N to SR 315 N, exit at Medical Center Dr/King Ave, and continue onto Medical Center Drive. Follow parking directions upon arrival.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance - Arthur G. James Cancer Hospital - Ohio State University** - **Financial Counseling Department:** For assistance with insurance benefits, programs for the uninsured or underinsured, billing inquiries, and Medicaid eligibility, contact (614) 685-5509. - **Insurance Inquiries:** - **Outpatient:** James Precertification Department, (614) 685-8998. - **Inpatient:** (614) 685-3371. - **Billing Department:** For billing questions, call (614) 293-2100. - **Online Resources:** Visit the Ohio State Medical Center and OSUCCC – James websites for information on accepted insurances and financial assistance options.
What insurance does Arthur G. James Cancer Hospital - Ohio State University accept?
The Arthur G. James Cancer Hospital - Ohio State University accepts a variety of insurance plans, including traditional Medicare and Medicare with Medigap coverage. For the most current list of accepted insurance plans, please visit their official website or contact the hospital directly.
What awards or recognition has Arthur G. James Cancer Hospital - Ohio State University received?
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, located at Ohio State University in Columbus, Ohio, is renowned for its outstanding cancer care, treatment, and research. It was honored with the Press Ganey Pinnacle of Excellence Award for Patient Experience in Inpatient Care in 2023.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.